Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Synthesis and Protease Inhibition. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103145608B reveals novel caprolactam synthesis for EV71 treatment offering scalable routes and cost reduction in pharmaceutical intermediate manufacturing.